(800) 424-6690

Montague Investigates Securities Fraud Allegations Against LifeStance Health Group, Inc.

Lead Plaintiff Deadline is October 11, 2022

Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) between June 7, 2021 and August 10, 2022 (the “Class Period”).

If you purchased the securities of LifeStance during the Class Period, would like to discuss Berger Montague’s investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Michael Dell’Angelo at mdellangelo@bm.net or (215) 875-3080.

Join the Class Action Against Lifestance Health Group Inc.

Thank you! Your form has been successfully submitted.

About the Case

According to a recently filed lawsuit, LifeStance's IPO Registration Statement failed to disclose that: (1) the number of virtual visits clients were undertaking utilizing LifeStance was decreasing as the COVID-19 lockdowns were being lifted, thereby flatlining the Company's out-patient/virtual revenue growth; (2) operating expenses increased as clients' in-person visits increased in response to lifting of lockdown orders; and (3) physician burnout rate had risen, driving physician retention well below 87%, necessitating additional costs.

At the time of the filing of the complaint, LifeStance shares had fallen more than 70% from the IPO price.

About Berger Montague

Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.